Keyphrases
Multiple Myeloma
100%
Chemokine Ligand 12 (CXCL12)
100%
CXCR7
100%
Cell Adhesion Mediated Drug Resistance (CAM-DR)
100%
NOX-A12
100%
Bone Marrow
80%
Myeloma
60%
Myeloma Cells
60%
Plerixafor
60%
Bortezomib
40%
C-X-C Chemokine Receptor Type 4 (CXCR4)
40%
Adhesion
20%
Phase II Study
20%
Vorinostat
20%
Protease Inhibitors
20%
Chemotaxis
20%
Cluster of Differentiation 44 (CD44)
20%
Stromal Cell-derived factor-1 (SDF-1)
20%
Cytotoxic Effect
20%
Carfilzomib
20%
Co-treatment
20%
Pomalidomide
20%
CD49d
20%
CXCR4 Inhibitor
20%
Stroma Cells
20%
Myeloma Therapy
20%
Underlining
20%
Co-sensitization
20%
Bone Marrow Stroma Cells
20%
ITGA4
20%
Immunology and Microbiology
Drug Resistance
100%
Multiple Myeloma
100%
Cell Adhesion
100%
CXCR7
100%
Plerixafor
50%
CXCR4
50%
Myeloma Cell
50%
Mediator
16%
Coculture
16%
Proteasome
16%
Cytotoxicity
16%
Chemotaxis
16%
Dexamethasone
16%
CD44
16%
CD49d
16%
Pomalidomide
16%
Stroma Cell
16%
Bone Marrow Stroma Cell
16%
Stromal Cell-Derived Factor 1
16%
Agricultural and Biological Sciences
Bone Marrow
100%
CXCR7
100%
Cell Adhesion
100%
CXCR4
60%
Receptor
20%
Chemotaxis
20%
Coculture
20%
Stromal Cell-Derived Factor 1
20%
CD44
20%
CD49d
20%
Proteasome
20%
Dexamethasone
20%
Cytotoxicity
20%